logo
Intel's credit rating downgraded by Fitch on demand challenges

Intel's credit rating downgraded by Fitch on demand challenges

CNBC3 days ago
Fitch downgrading U.S. chipmaker Intel's credit rating by one notch Monday, according to a note by the ratings agency, which assigned a negative outlook to Intel's rating.
Fitch downgraded Intel to BBB from BBB-plus, placing it just two notches shy of junk credit status.
The downgrade follows Fitch's assessment that Santa Clara, California-headquartered Intel faces heightened challenges maintaining demand for its products. Fitch cited growing competition from peers such as Dutch rival NXP Semiconductors, Broadcom Inc and Advanced Micro Devices.
"Credit metrics remain weak and will require both stronger end markets and successful product ramps, along with net debt reduction over the next 12-14 months" for Intel to recover its recent ratings, Fitch analysts wrote on Monday.
Fitch added that while Intel holds a better market position than other similarly rated peers, its financial structure is relatively weaker and it faces "higher execution risk."
Intel still enjoys a strong market position in the provision of PCs and traditional enterprise servers, Fitch noted, while warning the company faces heightened PC competition from Qualcomm and AMD.
Intel will need to ramp up its PC shipments while also reducing its balance sheet debt to recover its previous credit ratings, Fitch said.
The ratings agency called Intel's liquidity profile "solid," which as of June 28 consisted of a $21.2 billion mix of cash, cash equivalents and short-term investments, as well as an untapped $7 billion credit revolver. It also had an undrawn $5 billion, 364-day revolver that will come due in January 2026, Fitch said.
Fellow ratings agency S&P Global similarly downgraded Intel's credit rating to BBB from BBB-plus in December, while Moody's Ratings downgraded its senior unsecured debt's rating in August last year.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Claimable Expands Advisory Board with ERISA Litigation Pioneer D. Brian Hufford and Renowned Healthcare Advocate Dr. Elisabeth Potter
Claimable Expands Advisory Board with ERISA Litigation Pioneer D. Brian Hufford and Renowned Healthcare Advocate Dr. Elisabeth Potter

Yahoo

time17 minutes ago

  • Yahoo

Claimable Expands Advisory Board with ERISA Litigation Pioneer D. Brian Hufford and Renowned Healthcare Advocate Dr. Elisabeth Potter

Hufford Joins as Senior Legal Advisor; Dr. Potter as Senior Clinical Advisor SACRAMENTO, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Claimable, the AI-powered appeals platform redefining how patients challenge insurance denials, today announced the appointment of two nationally recognized experts to its advisory board. D. Brian Hufford, former partner at Zuckerman Spaeder LLP and currently the Principal at The Hufford Law Firm PLLC, joins as Senior Legal Advisor. Dr. Elisabeth Potter, board-certified plastic surgeon and healthcare advocate, joins as Senior Clinical Advisor. Claimable combines legal precedent and clinical expertise with policy details and the patient's unique medical story to deliver personalized, evidence-backed appeals. Built to bridge the gap between the law, medicine, and the lived patient experience, Claimable ensures appeals reflect both institutional requirements and individual realities. Hufford and Dr. Potter's appointments further strengthen Claimable's position as the trusted leader in AI-powered appeals, grounded in regulatory rigor and real-world clinical insight. 'We're proud to welcome advocates like Brian and Elisabeth as advisors at Claimable. Both have built their careers on unwavering integrity, ensuring that patients receive the care they deserve. Brian does this through his groundbreaking legal work, and Elisabeth through her fearless patient advocacy and deep clinical expertise. Together, they strengthen Claimable's ability to protect patient rights on every front,' said Warris Bokhari, CEO & Co‑Founder of Claimable. Brian Hufford is nationally recognized and celebrated for his trailblazing work in ERISA litigation, securing precedent-setting rulings and settlements against insurers on behalf of patients and fiduciaries. As Claimable's Senior Legal Advisor, he will guide legal strategy, help define best practices for insurance appeals, and support expansion across complex state and federal frameworks. 'For decades, I've fought to hold insurers accountable under laws designed to protect patients,' said Hufford. 'As technology rapidly evolves, new systemic challenges are emerging. Claimable can serve as an important part of the antidote, setting a new standard that combines legal rigor with AI-powered accessibility to put the power to fight denials where it belongs: in patients' hands. It can provide a transformative step toward a healthcare system that is fairer, more transparent, and more just. I'm excited to support the Claimable team and their mission to bring real accountability and real relief to patients across the country.' Dr. Elisabeth Potter is a Texas-based reconstructive plastic surgeon who became a national voice for patients and physicians after going public in January 2025 about being called mid-surgery by UnitedHealthcare regarding a patient's coverage. Her viral video drew widespread support and highlighted how insurance interference can impede physician autonomy and compromise care. As Claimable's Senior Clinical Advisor, she will ensure that emerging clinical realities, especially the challenges physicians face in advocating for care, are reflected in the design of Claimable's products and services. 'When insurance companies interfere with clinical decisions, patients suffer—and so does trust in the healthcare system. Claimable is changing that by giving patients a simple, affordable, data-backed path to challenge unfair denials,' said Dr. Potter. 'I'm particularly passionate about women's health and expanding access to affordable care. By supporting numerous conditions that disproportionately affect women, Claimable is proving to be a powerful tool for those so often impacted by our broken insurance system. I'm excited to bring the physician perspective to this work and help empower both patients and doctors to advocate for the care they know is right.' These appointments follow a period of rapid growth and product expansion. Since launching in late 2024, Claimable has recovered over $15 million for patients, maintaining an overall success rate of over 80% across more than 70 commonly denied treatments, including autoimmune and migraine medications, IVIG for children with PANS/PANDAS, and GLP-1s for obesity and type 2 diabetes. Most recently, the company was named an honoree in Fast Company's 2025 World Changing Ideas Awards. To learn more about Claimable, visit ABOUT CLAIMABLEClaimable is revolutionizing the way patients and providers fight healthcare denials, helping ensure everyone has access to the care they need and the coverage they deserve. The platform leverages custom-built AI to analyze clinical research, policy details, appeals data, and patients' unique medical stories, generating and submitting customized appeals in minutes. Claimable is available nationwide, accepting denials from all insurance providers, including Medicare and Medicaid. As an NVIDIA Inception Program member, Claimable continues to push the boundaries of AI innovation in healthcare. For more information visit ContactEmily Foxpress@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Nuvia Dental Implant Center to Open Seven New Locations in Second Half of 2025
Nuvia Dental Implant Center to Open Seven New Locations in Second Half of 2025

Yahoo

time17 minutes ago

  • Yahoo

Nuvia Dental Implant Center to Open Seven New Locations in Second Half of 2025

SALT LAKE CITY, Aug. 7, 2025 /PRNewswire/ -- Nuvia Dental Implant Center is expanding access to its full arch dental implant treatment with seven new locations scheduled to open across the U.S. in the second half of 2025. The new centers will be located in: Harrison, NY (September) Fremont, CA (September) Richmond, VA (October) Fort Mill, SC (October) Torrance, CA (October) Fresno, CA (November) Kansas City, KS (November) Each new location will offer Nuvia's Permanent Teeth in 24 Hours — a process that gives patients permanent, custom zirconia teeth just 24 hours after surgery. This life-changing approach removes the need for temporary dentures (healing teeth), multiple fitting appointments, or waiting months for permanent teeth. Making Permanent Teeth in 24 Hours More Accessible Nuvia's process is different from traditional dental implant treatment. While many clinics use temporary sets of teeth and require several appointments over many months, Nuvia provides patients with fixed, permanent teeth the very next day after surgery. This is made possible by combining several parts of the process under one roof: A full team that includes an oral surgeon, a restorative dentist, and a certified nurse anesthetist An in-house lab at every center Advanced 3D planning technology By handling the full process from start to finish (and not relying on outsourcing form 3rd parties), each Nuvia location is able to deliver fast, high-quality results all while prioritizing safety, comfort, and dental implant success. The upcoming locations are expected to help serve both local patients and traveling patients who often struggle to find qualified providers offering full arch dental implants in their area. Changing Lives Across the US With thousands of people across the country struggling with failing or missing teeth, more and more patients are looking for a permanent solution. Many patients have spent years in pain or frustration, trying partials, crowns, root canals, or removable dentures — without long-term success. Nuvia's expanding network of centers is designed to meet that need by bringing a permanent, life-changing solution to more people, closer to where patients live. The new centers also help support out-of-town patients who are looking for 24 hour permanent teeth and are willing to travel to Nuvia. Locations like Torrance, Fremont, and Fresno expand Nuvia's reach in California while cities like Kansas City, Richmond, and Fort Mill provide new access points in the Midwest and Southeast. Each location follows the same process and standards, offering a safe and consistent patient experience no matter where treatment takes place. A Different Kind of Dental Implant Experience Compared to decades-old traditional methods, what Nuvia is doing is truly unique. Backed by years of research and use of the latest technology, Permanent Teeth in 24 Hours is incredibly successful. Nuvia's dental implant success rate in 2024 was 99.13%. This compares impressively to the 93-98% success rate reported in large studies of other dental implant providers. (1). About Nuvia Dental Implant Center Nuvia Dental Implant Center provides full mouth dental implants using a process that delivers permanent teeth just 24 hours after surgery. With in-house labs, a dedicated three-provider team, and advanced planning, Nuvia helps patients get a permanent new smile, designed to last a lifetime without temporary dentures or long delays. To see if you may be a candidate for permanent teeth in 24 hours, take the 60-second quiz Sources:Source: (1) Pjetursson, B. E., Thoma, D., Jung, R., Zwahlen, M., & Zembic, A. (2012). A systematic review of the survival and complication rates of implant-supported fixed dental prostheses (FDPs) after a mean observation period of at least 5 years. Clinical Oral Implants Research, 23(Suppl 6), 22-38. Media Contact: marketing@ View original content to download multimedia: SOURCE Nuvia Dental Implant Center Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Why is Trump going after Intel's CEO?
Why is Trump going after Intel's CEO?

Fast Company

time19 minutes ago

  • Fast Company

Why is Trump going after Intel's CEO?

Shares of Intel dropped more than 3% Thursday after President Donald Trump demanded the immediate resignation of the chipmaker's CEO. Claiming that there is 'no other solution to this problem,' Trump said Lip-Bu Tan is 'highly conflicted' in an early-morning post on Truth Social. Though the president didn't elaborate on his reasoning, Reuters has previously reported that Tan, either directly or through venture funds, has invested at least $200 million in Chinese manufacturing and chip companies. Intel shares dropped as much as 3.5% before recovering some of those losses. Tan caught the ire of Trump one day after Sen. Tom Cotton, a Republican from Arkansas, called Tan's ties to Chinese firms 'concerning' and questioned the potential impact on U.S. national security in a letter he sent to Frank Yeary, Intel's chairman. In his letter, Cotton requested that Yeary respond by next week to questions about Tan's ties to Chinese firms and his prior tenure as CEO of Cadence Design Systems, which last month agreed to plead guilty in a past criminal case. He also cited Intel's receipt of nearly $8 billion in funding under the CHIPS and Science Act during Joe Biden's presidency last year. 'Intel is required to be a responsible steward of American taxpayer dollars and to comply with applicable security regulations,' Sen. Cotton wrote. 'Mr. Tan's associations raise questions about Intel's ability to fulfill these obligations.' TAN AND TRUMP Tan's past investments came under scrutiny following his appointment as CEO, though as a former venture capitalist the size and scope is perhaps not so unusual. A Reuters investigation found that Tan's investments in China were made through Walden International, the venture capital firm he founded in 1987, along with two Hong Kong-based holding companies. Reuters said it found no evidence that Tan was invested directly in any company that's banned by the U.S. Treasury's Chinese Military-Industrial Complex Companies List. What's more, Walden International wasn't an anomaly: It was one of five American venture capital firms that were the subject of a congressional investigation last year into investments in China's semiconductor industry that totaled $1 billion since 2001. The other funds on the list were GGV Capital, GSR Ventures, Qualcomm Ventures, and Sequoia Capital. But Walden International and, by virtue Tan, may be out of favor by the Trump administration for other reasons. GGV Capital split its U.S. and China operations into two firms last year, while GSR Ventures did so this year. Qualcomm donated $1 million to a nonprofit that supported Trump's 2024 election bid, while Shaun Maguire, one of Sequoia's partners, is a vocal Trump supporter and the firm has ties to David Sacks, the White House AI and crypto czar. As recently as March, Tan said the Trump administration was prepared to help Intel so the U.S. can maintain semiconductor leadership — and he would seek the administration's help, as needed. On Wednesday, Trump threatened a 100% tariff on imported semiconductors and chips, which would actually favor Intel as it has domestic facilities. Even if information about Tan's investments are known, it's trickier to track the personal investments of CEOs in foreign companies as they're not required to disclose that information unless there's a potential conflict of interest. But sometimes their investments do catch the eye of watchdogs. Last year, for example, Campaign for Accountability, a Washington, D.C.-based nonprofit that runs the Tech Transparency Project, reported that former Google CEO Eric Schmidt had invested nearly $17 million through his private foundation into the Chinese AI industry, even as he was leading the National Security Commission on Artificial Intelligence. INTEL'S WOES The Santa Clara, California-based company issued a statement in response on Wednesday, saying: 'Intel and Tan are deeply committed to the national security of the U.S. and the integrity of our role in the U.S. defense ecosystem.' The company hasn't responded to Trump's call for Tan's immediate resignation, according to reporting by other news outlets. Tan was appointed as CEO of Intel in March, replacing Pat Gelsinger, who was forced out in late-2024 after the board of directors lost confidence in his turnaround plans for the company. In his first few months, Tan has already embarked on an aggressive plan to streamline the organization with a plan for more layoffs, to the tune of about 15%. In a letter to employees in July when Intel reported second-quarter financial results, Tan said such efforts are 'steps in the right direction.' REACTIONS TO TRUMP'S POST On social media, several commenters questioned whether Intel will 'bend the knee' and submit to Trump's call for Tan's resignation. Analysts also weighed in about the implications of the president's post. 'Unfortunately, unlike other tech CEOs, Lip-Bu does not appear to have cultivated the kind of personal relationship with Trump that would help to assuage his ire,' Bernstein analyst Stacy Rasgon said in a note to clients. And Trump's apparent meddling in corporate leadership could be setting 'a very unfortunate precedent,' Phil Blancato, CEO of Ladenburg Thalmann Asset Management, which does not own Intel shares, told Reuters. 'You don't want American presidents dictating who runs companies, but certainly his opinion has merit and weight.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store